Page last updated: 2024-10-26

erythrosine and Cardiomyopathy, Hypertrophic

erythrosine has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borovikov, IuS1
Karpicheva, OE1
Rysev, NA1
Redwood, CS1

Other Studies

1 other study available for erythrosine and Cardiomyopathy, Hypertrophic

ArticleYear
[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2013, Volume: 99, Issue:1

    Topics: Actin Cytoskeleton; Actins; Adenosine Triphosphatases; Adenosine Triphosphate; Cardiomyopathy, Dilat

2013